Faron Pharmaceutics Reports Inconsistent Traumakine Biomarker Results
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Thursday said preliminary biomarker data from its Traumakine phase III trial has produced inconsistent results.Faron is testing in a III
Read more